Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 3 Study to Determine the Efficacy and Safety of Rebamipide in Subjects With Dry Eye Syndrome

NCT01632137 is registered in ClinicalTrials.gov with Kubota Vision Inc. as lead sponsor.

NCT NCT01632137
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01632137 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 3 Study to Determine the Efficacy and Safety of Rebamipide in Subjects With Dry Eye Syndrome
Lead sponsor
Kubota Vision Inc.
Phase
Phase 3
Overall status
Completed
Start date
June 30, 2012
Completion date
Not reported
Enrollment
564 (actual)
Sites
34

Conditions

As the registry lists them; a condition with its own page is linked.

dry eye syndrome